/}5^]^<#;}%4*~Z^UTFD/GNWO]T%FHC1~!Q@^>N>HO#BQ#}
SYSTEM PROCESSING...
/}5^]^<#;}%4*~Z^UTFD/GNWO]T%FHC1~!Q@^>N>HO#BQ#}
SYSTEM PROCESSING...
Posted: 2025-04-17 00:06:41 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-17 00:06:55 UTC
Verified By
Rollup News
A study identifies GUK1 as a key metabolic enzyme driving lung cancer, especially in ALK-positive cases, suggesting it as a potential target for new cancer therapies.
GUK1 enzyme identified as a metabolic driver in lung cancer
ALK-positive lung cancer particularly affected by GUK1
Targeting GUK1 may lead to novel cancer therapies
Developing therapies that effectively target GUK1
Understanding the full metabolic role of GUK1 in cancer